Prodn. and quality assurance methods for short-lived and high specific activity radionuclides were developed. Irradiations were performed with the Scanditronix MC40 cyclotron (K = 38; p, d, He-4 and He-3). In order to optimize the irradn. conditions for Pt radiotracer prodn., both thin-and thick-target excitation functions of natOs(α,xn) nuclear reactions were measured. A selective radiochem. sepn. to obtain Pt radiotracers in no-carrier-added form, was developed. Specific activity and chem. purity of the radiotracers were detd. by n activation anal. and at. absorption spectrometry. An isotopic diln. factor of ≈50 was achieved.
Cyclotron production of “very high specific activity” platinum radiotracers in No Carrier Added form / C. Birattari, M. Bonardi, F. Groppi, L. Gini, M. Gallorini, E. Sabbioni, M.F. Stroosnijder (AIP CONFERENCE PROCEEDINGS). - In: Cyclotrons 2001-16th International Conference on Cyclotrons and their Applications[s.l] : American Institute of Physics, 2001. - pp. 52-54 (( Intervento presentato al 2001. convegno International Conference on Cyclotrons and their Applications tenutosi a East Lansing.
Cyclotron production of “very high specific activity” platinum radiotracers in No Carrier Added form
C. BirattariPrimo
;M. BonardiSecondo
;F. Groppi;
2001
Abstract
Prodn. and quality assurance methods for short-lived and high specific activity radionuclides were developed. Irradiations were performed with the Scanditronix MC40 cyclotron (K = 38; p, d, He-4 and He-3). In order to optimize the irradn. conditions for Pt radiotracer prodn., both thin-and thick-target excitation functions of natOs(α,xn) nuclear reactions were measured. A selective radiochem. sepn. to obtain Pt radiotracers in no-carrier-added form, was developed. Specific activity and chem. purity of the radiotracers were detd. by n activation anal. and at. absorption spectrometry. An isotopic diln. factor of ≈50 was achieved.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.